تقرير
أعرض في EDS

Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer.

التفاصيل البيبلوغرافية
العنوان: Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer.
المؤلفون: Zhang T; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Genitourinary Cancer Institute, Shanghai, China., Wei Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Genitourinary Cancer Institute, Shanghai, China., Hong BH; Division of Medical Sciences, National Cancer Centre Singapore, Singapore., Sumiyoshi T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Ong EHW; Division of Medical Sciences, National Cancer Centre Singapore, Singapore., Zeng H; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China., Li Y; Department of Urology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Ng CF; Department of Surgery, and SH Ho Urology Center, Chinese University of Hong Kong, Hong Kong, Hong Kong., Pan J; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Genitourinary Cancer Institute, Shanghai, China., Fang B; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Genitourinary Cancer Institute, Shanghai, China., Wang B; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Genitourinary Cancer Institute, Shanghai, China., Wu J; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Genitourinary Cancer Institute, Shanghai, China., Wang H; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Genitourinary Cancer Institute, Shanghai, China., Akamatsu S; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Urology, Nagoya University Graduate School of Medicine, Aichi, Japan., Chua MLK; Division of Medical Sciences, National Cancer Centre Singapore, Singapore.; Department of Head and Neck and Thoracic Cancers, Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore., Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Genitourinary Cancer Institute, Shanghai, China., Zhu Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Genitourinary Cancer Institute, Shanghai, China.
المصدر: Clinical and translational medicine [Clin Transl Med] 2023 Sep; Vol. 13 (9), pp. e1411.
نوع المنشور: Letter; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326 (Electronic) Linking ISSN: 20011326 NLM ISO Abbreviation: Clin Transl Med Subsets: MEDLINE
أسماء مطبوعة: Publication: 2020- : [Hoboken, NJ] : Wiley
Original Publication: Heidelberg : Springer-Verlag
مواضيع طبية MeSH: Nomograms* , Prostatic Neoplasms*/diagnosis , Prostatic Neoplasms*/genetics, Male ; Humans ; DNA Damage/genetics ; Germ Cells
References: Oncoscience. 2018 Apr 29;5(3-4):62-64. (PMID: 29854870)
Ann Oncol. 2020 Sep;31(9):1119-1134. (PMID: 32593798)
Eur Urol. 2020 Jan;77(1):38-52. (PMID: 31493960)
J Clin Oncol. 2020 Aug 20;38(24):2798-2811. (PMID: 32516092)
N Engl J Med. 2015 Oct 29;373(18):1697-708. (PMID: 26510020)
J Urol. 2022 Sep;208(3):505-507. (PMID: 35830561)
Br J Cancer. 2022 Nov;127(9):1680-1690. (PMID: 35986085)
Eur Urol. 2022 Jul;82(1):115-141. (PMID: 35450732)
تواريخ الأحداث: Date Created: 20230913 Date Completed: 20230914 Latest Revision: 20230928
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10497832
DOI: 10.1002/ctm2.1411
PMID: 37700486
قاعدة البيانات: MEDLINE
الوصف
تدمد:2001-1326
DOI:10.1002/ctm2.1411